B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-13Clinical Trial Update: A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies [Phase 1]
A Phase I trial of donor-derived 19-28z CAR T cells following allogeneic transplant for CD19 malignancies has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-05-06Clinical Trial Update: PD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCL [Phase 1]
Phase 1 trial evaluating PD-1, LAG-3, and TIM-3 checkpoint blockade for diffuse large B-cell lymphoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-21Clinical Trial Update: QUILT-3.061: CD19 t-haNK in Subjects With Diffuse Large B-Cell Lymphoma [Phase 1]
A Phase 1 trial of CD19 t-haNK for diffuse large B-cell lymphoma has been withdrawn.
-
EMA withdrawal · 2023-02-10EMA Application withdrawn: Aliqopa (copanlisib dihydrochloride) — Bayer AG
The EMA has withdrawn the application for Aliqopa (copanlisib dihydrochloride) by Bayer AG for its use in lymphoma subtypes including margin…
-
CLINICAL_TRIALS withdrawal · 2016-10-14Clinical Trial Update: R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma [Phase 2]
A phase 2 trial of R-CHOP-B (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone plus Bevacizumab) for diffuse large B-cell ly…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-03-30Clinical Trial Update: A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis [Phase 1]
The Phase I study of intrathecal rituximab for lymphomatous meningitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-23Clinical Trial Update: Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue [NA]
A clinical trial evaluating armodafinil for patients with B-cell lymphoma and fatigue has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2008-09-05Clinical Trial Update: A Phase I Study to Evaluate Safety, Tolerability in Adults With Lymphoma [Phase 1]
This Phase I study evaluating safety and tolerability in adults with lymphoma has been withdrawn.